These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression. Parkinson Study Group JAMA; 2002 Apr; 287(13):1653-61. PubMed ID: 11926889 [TBL] [Abstract][Full Text] [Related]
17. A multicenter assessment of dopamine transporter imaging with DOPASCAN/SPECT in parkinsonism. Parkinson Study Group. Neurology; 2000 Nov; 55(10):1540-7. PubMed ID: 11094111 [TBL] [Abstract][Full Text] [Related]
18. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients. Seibyl JP; Marek K; Sheff K; Zoghbi S; Baldwin RM; Charney DS; van Dyck CH; Innis RB J Nucl Med; 1998 Sep; 39(9):1500-8. PubMed ID: 9744331 [TBL] [Abstract][Full Text] [Related]
19. Test/retest reproducibility of iodine-123-betaCIT SPECT brain measurement of dopamine transporters in Parkinson's patients. Seibyl JP; Marek K; Sheff K; Baldwin RM; Zoghbi S; Zea-Ponce Y; Charney DS; van Dyck CH; Hoffer PB; Innis RB J Nucl Med; 1997 Sep; 38(9):1453-9. PubMed ID: 9293807 [TBL] [Abstract][Full Text] [Related]
20. Erlotinib: CP 358774, NSC 718781, OSI 774, R 1415. Adis International Ltd Drugs R D; 2003; 4(4):243-8. PubMed ID: 12848590 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]